-
Je něco špatně v tomto záznamu ?
Biphenotypic sinonasal sarcoma with PAX3::MAML3 fusion transforming into high-grade rhabdomyosarcoma: report of an emerging rare phenomenon
A. Meyer, N. Klubíčková, E. Mosaieby, P. Grossmann, A. Kalmykova, O. Koshyk, M. Michal
Jazyk angličtina Země Německo
Typ dokumentu kazuistiky, časopisecké články
Grantová podpora
SVV 260539
Ministerstvo Školství, Mládeže a Tělovýchovy
Cooperatio program, SURG
Ministerstvo Školství, Mládeže a Tělovýchovy
NLK
ProQuest Central
od 2003-01-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2011-01-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest)
od 2003-01-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 2003-01-01 do Před 1 rokem
- MeSH
- alveolární rhabdomyosarkom * MeSH
- desmin MeSH
- imunohistochemie MeSH
- lidé středního věku MeSH
- lidé MeSH
- myogenin MeSH
- nádorové biomarkery genetika MeSH
- nádory měkkých tkání * genetika MeSH
- nádory vedlejších dutin nosních * patologie MeSH
- proteiny S100 MeSH
- rhabdomyosarkom * genetika MeSH
- sarkom * genetika MeSH
- trans-aktivátory MeSH
- transkripční faktor PAX3 genetika MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
We report a case of a 67-year-old male patient with a sinonasal tumor that showed areas of classic biphenotypic sinonasal sarcoma (BSNS) which in some sections sharply transitioned into high-grade rhabdomyosarcoma. Immunohistochemically, the conventional BSNS parts showed S100 protein, SMA, PAX7, and focal MyoD1 expression, whereas desmin and myogenin were negative. In contrast, the cells in high-grade areas expressed desmin, MyoD1, myogenin, and PAX7, while being negative for S100 protein and SMA. Using the Archer FusionPlex assay, the classical PAX3::MAML3 gene fusion was detected. FISH for PAX3 and MAML3 confirmed a break of these genes in both components. Despite aggressive therapy, the tumor progression resulted in the patient's death. The herein presented case, together with 2 previously published cases of BSNS with high-grade transformation, helps to better understand this novel phenomenon. Although the risk for such transformation appears low, it has important clinical and diagnostic implications which are discussed.
Bioptical Laboratory Ltd Plzen Czech Republic
Department of Pathology University of Kansas KS Kansas City USA
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23010566
- 003
- CZ-PrNML
- 005
- 20230801132511.0
- 007
- ta
- 008
- 230718s2023 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00428-023-03501-0 $2 doi
- 035 __
- $a (PubMed)36719455
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Meyer, Anders $u Department of Pathology, University of Kansas, KS, Kansas City, USA
- 245 10
- $a Biphenotypic sinonasal sarcoma with PAX3::MAML3 fusion transforming into high-grade rhabdomyosarcoma: report of an emerging rare phenomenon / $c A. Meyer, N. Klubíčková, E. Mosaieby, P. Grossmann, A. Kalmykova, O. Koshyk, M. Michal
- 520 9_
- $a We report a case of a 67-year-old male patient with a sinonasal tumor that showed areas of classic biphenotypic sinonasal sarcoma (BSNS) which in some sections sharply transitioned into high-grade rhabdomyosarcoma. Immunohistochemically, the conventional BSNS parts showed S100 protein, SMA, PAX7, and focal MyoD1 expression, whereas desmin and myogenin were negative. In contrast, the cells in high-grade areas expressed desmin, MyoD1, myogenin, and PAX7, while being negative for S100 protein and SMA. Using the Archer FusionPlex assay, the classical PAX3::MAML3 gene fusion was detected. FISH for PAX3 and MAML3 confirmed a break of these genes in both components. Despite aggressive therapy, the tumor progression resulted in the patient's death. The herein presented case, together with 2 previously published cases of BSNS with high-grade transformation, helps to better understand this novel phenomenon. Although the risk for such transformation appears low, it has important clinical and diagnostic implications which are discussed.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a nádorové biomarkery $x genetika $7 D014408
- 650 _2
- $a desmin $7 D003893
- 650 _2
- $a imunohistochemie $7 D007150
- 650 _2
- $a myogenin $7 D018008
- 650 12
- $a nádory vedlejších dutin nosních $x patologie $7 D010255
- 650 _2
- $a transkripční faktor PAX3 $x genetika $7 D000072041
- 650 12
- $a rhabdomyosarkom $x genetika $7 D012208
- 650 12
- $a alveolární rhabdomyosarkom $7 D018232
- 650 _2
- $a proteiny S100 $7 D009418
- 650 12
- $a sarkom $x genetika $7 D012509
- 650 12
- $a nádory měkkých tkání $x genetika $7 D012983
- 650 _2
- $a trans-aktivátory $7 D015534
- 650 _2
- $a lidé středního věku $7 D008875
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Klubíčková, Natálie $u Department of Pathology, Faculty of Medicine, Charles University, Medical Faculty and Charles University Hospital Plzen, Alej Svobody 80, 323 00, Plzen, Czech Republic $u Bioptical Laboratory, Ltd., Plzen, Czech Republic
- 700 1_
- $a Mosaieby, Elaheh $u Department of Pathology, Faculty of Medicine, Charles University, Medical Faculty and Charles University Hospital Plzen, Alej Svobody 80, 323 00, Plzen, Czech Republic $u Bioptical Laboratory, Ltd., Plzen, Czech Republic
- 700 1_
- $a Grossmann, Petr $u Bioptical Laboratory, Ltd., Plzen, Czech Republic
- 700 1_
- $a Kalmykova, Antonina $u Department of Pathology, Faculty of Medicine, Charles University, Medical Faculty and Charles University Hospital Plzen, Alej Svobody 80, 323 00, Plzen, Czech Republic $u Medical Laboratory CSD Health Care, Ltd., Kyiv, Ukraine
- 700 1_
- $a Koshyk, Olena $u Department of Pathology, Faculty of Medicine, Charles University, Medical Faculty and Charles University Hospital Plzen, Alej Svobody 80, 323 00, Plzen, Czech Republic $u Medical Laboratory CSD Health Care, Ltd., Kyiv, Ukraine
- 700 1_
- $a Michal, Michael $u Department of Pathology, Faculty of Medicine, Charles University, Medical Faculty and Charles University Hospital Plzen, Alej Svobody 80, 323 00, Plzen, Czech Republic. michael.michal@biopticka.cz $u Bioptical Laboratory, Ltd., Plzen, Czech Republic. michael.michal@biopticka.cz
- 773 0_
- $w MED00004660 $t Virchows Archiv : an international journal of pathology $x 1432-2307 $g Roč. 482, č. 4 (2023), s. 777-782
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36719455 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230718 $b ABA008
- 991 __
- $a 20230801132508 $b ABA008
- 999 __
- $a ok $b bmc $g 1963158 $s 1196831
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 482 $c 4 $d 777-782 $e 20230131 $i 1432-2307 $m Virchows Archiv $n Virchows Arch $x MED00004660
- GRA __
- $a SVV 260539 $p Ministerstvo Školství, Mládeže a Tělovýchovy
- GRA __
- $a Cooperatio program, SURG $p Ministerstvo Školství, Mládeže a Tělovýchovy
- LZP __
- $a Pubmed-20230718